Voyager Therapeutics (VYGR) Stock Forecast & Price Target
VYGR Analyst Ratings
Strong Buy
5Buy0Hold0Sell
Based on 5 analysts giving stock ratings to Voyager Therapeutics in the past 3 months
VYGR Stock 12 Month Forecast
Average Price Target
MXN 258.31▲(761.03% Upside)Based on 5 Wall Street analysts offering 12 month price targets for Voyager Therapeutics in the last 3 months. The average price target is MXN 258.31 with a high forecast of MXN 469.65 and a low forecast of MXN 150.29. The average price target represents a 761.03% change from the last price of MXN 30.00.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 469.65
AverageMXN 258.31
LowMXN 150.29
Highest Price TargetHighestMXN 469.65Average Price TargetMXN 258.31Lowest Price TargetLowestMXN 150.29
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Patrick Trucchio | H.C. Wainwright | MXN 469.65 | buy | 1465.50%Upside | Reiterated | 10/28/26 | ||
| Sumant Kulkarni | Canaccord Genuity | MXN 225.43 | buy | 651.44%Upside | Reiterated | 10/23/26 | ||
 Unknown AnalystNot Ranked | Wells Fargo | MXN 187.86 | buy | 526.20%Upside | Reiterated | 10/02/26 | ||
| Yun Zhong | Wedbush | MXN 150.29 | buy | 400.96%Upside | Reiterated | 08/07/26 | ||
| Phil Nadeau | TD Cowen | ― | buy | ― | Reiterated | 08/06/26 | ||
| Debjit Chattopadhyay | Guggenheim | MXN 413.29 | buy | 1277.64%Upside | Reiterated | 06/02/26 | ||
| Unknown AnalystNot Ranked | Oppenheimer | MXN 338.15 | buy | 1027.16%Upside | Reiterated | 05/08/26 | ||
| Samantha Semenkow | Citi | MXN 206.65 | buy | 588.82%Upside | Reiterated | 03/23/26 | ||
| Joon Lee | UBS | ― | buy | ― | Reiterated | 03/17/26 | ||
| Lili (Aurélie) Nsongo | Leerink Partners | MXN 206.65 | buy | 588.82%Upside | Reiterated | 12/15/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Patrick Trucchio | 10/28/26 | MXN 469.65 | buy | 1465.50%Upside | Reiterated | H.C. Wainwright | ||
| Sumant Kulkarni | 10/23/26 | MXN 225.43 | buy | 651.44%Upside | Reiterated | Canaccord Genuity | ||
| Unknown AnalystNot Ranked | 10/02/26 | MXN 187.86 | buy | 526.20%Upside | Reiterated | Wells Fargo | ||
| Yun Zhong | 08/07/26 | MXN 150.29 | buy | 400.96%Upside | Reiterated | Wedbush | ||
| Phil Nadeau | 08/06/26 | ― | buy | ― | Reiterated | TD Cowen | ||
| Debjit Chattopadhyay | 06/02/26 | MXN 413.29 | buy | 1277.64%Upside | Reiterated | Guggenheim | ||
| Unknown AnalystNot Ranked | 05/08/26 | MXN 338.15 | buy | 1027.16%Upside | Reiterated | Oppenheimer | ||
| Samantha Semenkow | 03/23/26 | MXN 206.65 | buy | 588.82%Upside | Reiterated | Citi | ||
| Joon Lee | 03/17/26 | ― | buy | ― | Reiterated | UBS | ||
| Lili (Aurélie) Nsongo | 12/15/25 | MXN 206.65 | buy | 588.82%Upside | Reiterated | Leerink Partners |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Voyager Therapeutics
3 Months
Success Rate7/19 ratings generated profit
37%
Average Return
+0.54%
Copying Debjit Chattopadhyay's trades and holding each position for 3 Months would result in 36.84% of your transactions generating a profit, with an average return of +0.54% per trade.
1 Year
Success Rate11/28 ratings generated profit
39%
Average Return
-18.87%
Copying Sumant Kulkarni's trades and holding each position for 1 Year would result in 39.29% of your transactions generating a profit, with an average return of -18.87% per trade.
2 Years
Success Rate2/28 ratings generated profit
7%
Average Return
-34.08%
Copying Sumant Kulkarni's trades and holding each position for 2 Years would result in 7.14% of your transactions generating a profit, with an average return of -34.08% per trade.
VYGR Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 13 | 12 | 10 | 9 | 4 |
| Buy | 3 | 3 | 2 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 15 | 12 | 10 | 4 |
In the current month, VYGR has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VYGR average Analyst price target in the past 3 months is 258.31.
VYGR Financial Forecast
HighMXN -5.26
ConsensusMXN -7.87
LowMXN -15.03
VYGR Earnings Forecast
Next quarter’s earnings estimate for VYGR is -MXN 7.87 with a range of -MXN 15.03 to -MXN 5.26. The previous quarter’s EPS was -MXN 7.51. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 282M
ConsensusMXN 119M
LowMXN 582K
VYGR Sales Forecast
Next quarter’s sales forecast for VYGR is MXN 119.29M with a range of MXN 582.37K to MXN 281.79M. The previous quarter’s sales results were MXN 59.46M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
VYGR Stock Forecast FAQ
What is MX:VYGR’s average 12-month price target, according to analysts?
Based on analyst ratings, Voyager Therapeutics’s 12-month average price target is Mex$258.31.
What is MX:VYGR’s upside potential, based on the analysts’ average price target?
Voyager Therapeutics has 761.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Voyager Therapeutics a Buy, Sell or Hold?
Voyager Therapeutics has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Voyager Therapeutics’s share price target?
The average share price target for Voyager Therapeutics is Mex$258.31. This is based on 5 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$469.65, and the lowest forecast is Mex$150.29. The average share price target represents a 761.03% increase from the current price of Mex$30.
What do analysts say about Voyager Therapeutics?
Voyager Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of Voyager Therapeutics?
To buy shares of MX:VYGR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.